226 related articles for article (PubMed ID: 25562434)
21. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
22. Identification of factors that impact recurrence in patients with borderline ovarian tumors.
Chen X; Fang C; Zhu T; Zhang P; Yu A; Wang S
J Ovarian Res; 2017 Apr; 10(1):23. PubMed ID: 28376898
[TBL] [Abstract][Full Text] [Related]
23. [A retrospective study of tumor and fertility outcomes after fertility-sparing surgical treatment of patients with borderline ovarian tumors].
Liu F; Hu DH; Zhang YF; Wang B; Huang K; Wang CY; Xia XY
Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(47):3699-3703. PubMed ID: 29325322
[No Abstract] [Full Text] [Related]
24. The presence and location of epithelial implants and implants with epithelial proliferation may predict a higher risk of recurrence in serous borderline ovarian tumors: a clinicopathologic study of 188 cases.
Quddus MR; Sung CJ; Zhang C; Moore RG; Ou JJ; Steinhoff MM; Lawrence WD
Hum Pathol; 2012 May; 43(5):747-52. PubMed ID: 22047646
[TBL] [Abstract][Full Text] [Related]
25. Histopathologic features of ovarian borderline tumors are not predictive of clinical outcome.
Avril S; Hahn E; Specht K; Hauptmann S; Höss C; Kiechle M; Höfler H; Schmalfeldt B
Gynecol Oncol; 2012 Dec; 127(3):516-24. PubMed ID: 23000388
[TBL] [Abstract][Full Text] [Related]
26. Effect of surgical staging on 539 patients with borderline ovarian tumors: a Turkish Gynecologic Oncology Group study.
Guvenal T; Dursun P; Hasdemir PS; Hanhan M; Guven S; Yetimalar H; Goksedef BP; Sakarya DK; Doruk A; Terek MC; Saatli B; Guzin K; Corakci A; Deger E; Celik H; Cetin A; Ozsaran A; Ozbakkaloglu A; Kolusari A; Celik C; Keles R; Sagir FG; Dilek S; Uslu T; Dikmen Y; Altundag O; Ayhan A
Gynecol Oncol; 2013 Dec; 131(3):546-50. PubMed ID: 24016409
[TBL] [Abstract][Full Text] [Related]
27. Impact of surgical staging on prognosis in patients with borderline ovarian tumours: A meta-analysis.
Shim SH; Kim SN; Jung PS; Dong M; Kim JE; Lee SJ
Eur J Cancer; 2016 Feb; 54():84-95. PubMed ID: 26735354
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors and survival of borderline ovarian tumors in Rajavithi Hospital between 1979-2006 A.D.
Sornsukolrat S; Tuipae S
J Med Assoc Thai; 2012 Sep; 95(9):1141-8. PubMed ID: 23140030
[TBL] [Abstract][Full Text] [Related]
29. Impact of complete cytoreduction leaving no gross residual disease associated with radical cytoreductive surgical procedures on survival in advanced ovarian cancer.
Chang SJ; Bristow RE; Ryu HS
Ann Surg Oncol; 2012 Dec; 19(13):4059-67. PubMed ID: 22766983
[TBL] [Abstract][Full Text] [Related]
30. [Prognostic factors analysis in patients with ovarian malignant germ cell tumor treated with fertility-preserving surgery].
Yang ZJ; Wei RJ; Li L
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):898-904. PubMed ID: 23324188
[TBL] [Abstract][Full Text] [Related]
31. Survival and reproductive outcomes after fertility-sparing surgery performed for borderline epithelial ovarian tumor in Japanese adolescents and young adults: Results of a retrospective nationwide study.
Kuji S; Harada M; Yoshioka N; Kajiyama H; Satoh T; Mikami M; Shozu M; Enomoto T; Osuga Y; Suzuki N
J Obstet Gynaecol Res; 2022 Mar; 48(3):806-816. PubMed ID: 34951514
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors predicting recurrence in borderline ovarian tumors.
Wu TI; Lee CL; Wu MY; Hsueh S; Huang KG; Yeh CJ; Lai CH
Gynecol Oncol; 2009 Aug; 114(2):237-41. PubMed ID: 19481786
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study.
Suh-Burgmann E
Gynecol Oncol; 2006 Dec; 103(3):841-7. PubMed ID: 16793124
[TBL] [Abstract][Full Text] [Related]
34. Fertility preserving surgical treatment of borderline ovarian tumour: long-term consequence for fertility and recurrence.
Marcickiewicz J; Brännström M
Acta Obstet Gynecol Scand; 2006; 85(12):1496-500. PubMed ID: 17260228
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors.
Chang SJ; Ryu HS; Chang KH; Yoo SC; Yoon JH
Acta Obstet Gynecol Scand; 2008; 87(4):476-81. PubMed ID: 18382877
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for recurrence of borderline ovarian tumors in France: A multicenter retrospective study by the FRANCOGYN group.
Sangnier E; Ouldamer L; Bendifallah S; Huchon C; Collinet P; Bricou A; Mimoun C; Lecointre L; Graesslin O; Raimond E
J Gynecol Obstet Hum Reprod; 2021 Apr; 50(4):101961. PubMed ID: 33127559
[TBL] [Abstract][Full Text] [Related]
37. Borderline epithelial tumours of the ovary--a retrospective analysis of 31 cases.
Kane SV; Bharadwaj R; Tongaonkar HB
Indian J Cancer; 1999 Mar; 36(1):18-31. PubMed ID: 10810551
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis-shift between low-grade serous ovarian cancer and serous borderline ovarian tumor: A population-based study.
Matsuo K; Machida H; Grubbs BH; Matsuzaki S; Klar M; Roman LD; Sood AK; Gershenson DM
Gynecol Oncol; 2020 Apr; 157(1):21-28. PubMed ID: 31954535
[TBL] [Abstract][Full Text] [Related]
39. Borderline Ovarian Tumor in the Pediatric and Adolescent Population: A Case Series and Literature Review.
Childress KJ; Patil NM; Muscal JA; Dietrich JE; Venkatramani R
J Pediatr Adolesc Gynecol; 2018 Feb; 31(1):48-54. PubMed ID: 28899828
[TBL] [Abstract][Full Text] [Related]
40. High-risk borderline ovarian tumors: analysis of clinicopathological features and prognostic impact of different follow-up strategies.
Lorusso D; Ratti M; Ditto A; Raspagliesi F
Oncology; 2014; 87(3):183-92. PubMed ID: 25033912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
